, TABLE OF CONTENT
v& v& v&
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber........................................................................4
v& v& v& v& v& v& xv v& v& xv
Chapter 2. Review of Basic Principles of Pharmacology......................................................................................5
v& v& v& v& v& v& v&
Chapter 3. Rational Drug Selection .................................................................................................................... 11
v& v& v& v&
Chapter 4. Legal and Professional Issues in Prescribing .................................................................................... 14
v& v& v& v& v& v& v&
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
v& v& xv v&
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
v& v& v& v& v&
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................. 22
v& v& v& v&
Chapter 8. Herbal Therapies ............................................................................................................................... 28
v& v& v&
Chapter 9. Cannabis ............................................................................................................................................ 31
v& v&
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
v& v&
Chapter 11. Drugs Affecting the Autonomic Nervous System .......................................................................... 38
v& v& v& v& v& v& v&
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................ 45
v& v& v& v& v& v& v&
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................ 53
v& v& v& v& v& v& v& v&
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................ 61
v& v& v& v& v& v&
Chapter 15. Drugs Affecting the Hematological System ................................................................................... 65
v& v& v& v& v& v&
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
v& v& xv v& v& v& v& v& v&
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
v& v& xv v& v& v& v&
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................. 77
v& v& v& v& v& v&
Chapter19. Drugs Affecting theEndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ..................... 80
v& v& v& v& v& v& v& v&
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .......................... 83
v& v& xv v& v& v& v& v& v& v& v&
Chapter 21. Drugs Affecting the Reproductive System ..................................................................................... 86
v& v& v& v& v& v&
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................ 92
v& v& v& v& v& v& v&
Chapter 23. Drugs Affecting the Integumentary System ................................................................................... 96
v& v& v& v& v& v&
Chapter 24. Drugs Used to Treat Bacterial Infections .......................................................................................101
v& v& v& v& xv v& v&
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .......................................................105
v& v& v& v& xv v& v& v& v& v&
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................108
v& v& v& xv xv v& v&
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ..................................................................................111
v& v& v& xv v& v& v& v& v&
Chapter 28. Anemia ...........................................................................................................................................113
v& v&
Chapter 29. Anxiety and Depression .................................................................................................................116
v& v& v& v&
Chapter 30. Attention Deficit-Hyperactivity Disorder......................................................................................120
v& v& v& v&
Chapter 31. Asthma and Allergy .......................................................................................................................122
v& v& v& v&
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................125
v& v& v& v& v&
Chapter 33. Contraception .................................................................................................................................127
v& v&
Chapter 34. COVID-19: Acute and Chronic .....................................................................................................130
v& v& v& v& v&
Chapter 35. Dermatological Conditions ............................................................................................................134
v& v& v&
Chapter 36. Diabetes Management ....................................................................................................................138
v& v& v&
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ......................................................................146
v& v& v& v& xv v& v&
Chapter 38. Headaches .......................................................................................................................................149
v& v&
Chapter 39. Heart Failure...................................................................................................................................153
v& v& v&
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................158
v& v& v& v& xv v& v&
Chapter 41. Menopausal Hormone Therapy .....................................................................................................161
v& v& v& v&
,Chapter 42. Hyperlipidemia ...............................................................................................................................164
v& v&
Chapter 43. Hypertension...................................................................................................................................169
v& v&
Chapter 44. Hyperthyroidism and Hypothyroidism ..........................................................................................174
v& v& v& v&
Chapter 45. Obesity ...........................................................................................................................................177
v& v&
Chapter 46. Pain Management: Acute and Chronic Pain ..................................................................................181
v& v& v& v& v& v& v&
Chapter 47. Pneumonia ......................................................................................................................................185
v& v&
Chapter 48. Sexually Transmitted Diseases and Vaginitis ..................................................................................187
v& v& v& xv v& xv
Chapter 49. Substance Use Disorders ................................................................................................................190
v& v& v& v&
Chapter 50. Tuberculosis ...................................................................................................................................195
v& v&
Chapter51. UpperRespiratory Tract Infection, Pharyngitis, Sinusitis,Otitis Media, and Otitis Externa .............197
v& v& xv v& v& xv v& xv v&
Chapter 52. Urinary Tract Infections .................................................................................................................200
v& v& v& v&
Chapter 53. Women as Patients .........................................................................................................................203
v& v& v& v&
Chapter 54. Men as Patients ................................................................................................................................207
v& v& xv xv
Chapter 55. Pediatric Patients ............................................................................................................................209
v& v& v&
Chapter 57. Geriatric Patients ............................................................................................................................213
v& v& v&
, Woo 1
Pharmacotherapeutics for APN Prescribers, v& v& v& v& Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
v& v& xv xv v& xv v& xv v& v&
MULTIPLE CHOICE v&
1. Nurse practitioner prescriptive authority is regulated by:
v& v& v& v& v& v&
A. The National Council of State Boards of Nursing
v& v& v& v& v& xv v&
B. The U.S. Drug Enforcement Administration
v& v& v& xv
C. The State Board of Nursing for each state
v& v& xv v& v& v& v&
D. The State Board of Pharmacy
v& v& v& v&
ANS: v & v & C PTS: 1
2. Thebenefits to the patient of having an advanced practice registered nurse (APRN) prescriber in
v& xv xv v& v& v& xv v& xv v& v&
cl ude:
v&
A. Nurses knowmoreabout pharmacology than other prescribers becausethey takeit b
v& xv v& v& v& v& v& v&
ot h in their basic nursing program and in their APRN program.
v& v& v& v& v& v& v& xv v& v& v&
B. Nurses care for thepatient from a holistic approach and includethepatient in de
xv v& v& xv v& xv v& v& xv xv v&
c ision-making regarding their care.
v& v& v& v&
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
v& v& v& v& v& v& v& v& v&
D. APRNs are abletoprescribe independentlyinallstates, whereas a physician’s as
v& xv v& v& xv v&
s istant needs to have a physician supervising their practice.
v& v& v& v& v& v& v& v& v&
ANS: v & v & B PTS: 1
3. Clinical judgment in prescribing includes:
v& v& v& v&
A. Factoring in the cost to the patient of the medication prescribed
v& v& v& v& v& v& xv v& v& v&
B. Always prescribing the newest medication available for the diseaseprocess
v& v& v& v& v& v& v& v&
C. Handing out drug samples to poor patients
v& v& v& v& xv v&
D. Prescribing all generic medications to cut costs v& v& v& v& v& xv
ANS: v & v & A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
v& v& v& v& v& v& v& v& v& v&
A. Asking the patient what drug they think would work best for them
v& v& v& v& v& v& v& v& v& v& v&
B. Consulting nationally recognized guidelines for diseasemanagement
v& v& v& v& v&
C. Prescribing medications that are available as samples before writing a prescription
v& v& xv v& v& xv v& v& v& v&
D. Following U.S. Drug Enforcement Administration guidelines forprescribing
v& v& v& v& xv v&
ANS: v & v & B PTS: 1
5. Nonintentional nonadherence of drug therapy may occur due to:
v& v& v& v& v& v& v& v&
A. Belief that medication does not work
v& v& xv v& xv
B. Adverse drug reactions v& v&
C. Chronic conditions that require dailytherapy
v& v& v& v&
D. Forgetfulness ordistraction v&
ANS: v & v & D PTS: 1
v& v& v&
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber........................................................................4
v& v& v& v& v& v& xv v& v& xv
Chapter 2. Review of Basic Principles of Pharmacology......................................................................................5
v& v& v& v& v& v& v&
Chapter 3. Rational Drug Selection .................................................................................................................... 11
v& v& v& v&
Chapter 4. Legal and Professional Issues in Prescribing .................................................................................... 14
v& v& v& v& v& v& v&
Chapter 5. Adverse Drug Reactions .................................................................................................................... 16
v& v& xv v&
Chapter 6. An Introduction to Pharmacogenomics ............................................................................................. 19
v& v& v& v& v&
Chapter 7. Nutrition and Nutraceuticals ............................................................................................................. 22
v& v& v& v&
Chapter 8. Herbal Therapies ............................................................................................................................... 28
v& v& v&
Chapter 9. Cannabis ............................................................................................................................................ 31
v& v&
Chapter 10. Pharmacoeconomics ........................................................................................................................ 35
v& v&
Chapter 11. Drugs Affecting the Autonomic Nervous System .......................................................................... 38
v& v& v& v& v& v& v&
Chapter 12. Drugs Affecting the Central Nervous System ................................................................................ 45
v& v& v& v& v& v& v&
Chapter 13. Drugs Affecting the Cardiovascular and Renal Systems ................................................................ 53
v& v& v& v& v& v& v& v&
Chapter 14. Drugs Affecting the Respiratory System ........................................................................................ 61
v& v& v& v& v& v&
Chapter 15. Drugs Affecting the Hematological System ................................................................................... 65
v& v& v& v& v& v&
Chapter 16. Drugs Affecting the Immune System: Vaccines and Immunoglobulins .......................................... 69
v& v& xv v& v& v& v& v& v&
Chapter 17. Drugs Affecting the Immune System: Immunomodulators ............................................................. 75
v& v& xv v& v& v& v&
Chapter 18. Drugs Affecting the Gastrointestinal System ................................................................................. 77
v& v& v& v& v& v&
Chapter19. Drugs Affecting theEndocrineSystem: Pancreatic Hormones and Antidiabetic Drugs ..................... 80
v& v& v& v& v& v& v& v&
Chapter 20. Drugs Affecting the Endocrine System: Pituitary, Thyroid, and Adrenal Drugs .......................... 83
v& v& xv v& v& v& v& v& v& v& v&
Chapter 21. Drugs Affecting the Reproductive System ..................................................................................... 86
v& v& v& v& v& v&
Chapter 22. Drugs Affecting the Bones and Joints ............................................................................................ 92
v& v& v& v& v& v& v&
Chapter 23. Drugs Affecting the Integumentary System ................................................................................... 96
v& v& v& v& v& v&
Chapter 24. Drugs Used to Treat Bacterial Infections .......................................................................................101
v& v& v& v& xv v& v&
Chapter 25. Drugs Used to Treat Viral, Fungal, and Protozoal Infections .......................................................105
v& v& v& v& xv v& v& v& v& v&
Chapter 26. Drugs Used to Treat Inflammatory Processes ................................................................................108
v& v& v& xv xv v& v&
Chapter 27. Drugs Used to Treat Eye and Ear Disorders ..................................................................................111
v& v& v& xv v& v& v& v& v&
Chapter 28. Anemia ...........................................................................................................................................113
v& v&
Chapter 29. Anxiety and Depression .................................................................................................................116
v& v& v& v&
Chapter 30. Attention Deficit-Hyperactivity Disorder......................................................................................120
v& v& v& v&
Chapter 31. Asthma and Allergy .......................................................................................................................122
v& v& v& v&
Chapter 32. Chronic Obstructive Pulmonary Disease .......................................................................................125
v& v& v& v& v&
Chapter 33. Contraception .................................................................................................................................127
v& v&
Chapter 34. COVID-19: Acute and Chronic .....................................................................................................130
v& v& v& v& v&
Chapter 35. Dermatological Conditions ............................................................................................................134
v& v& v&
Chapter 36. Diabetes Management ....................................................................................................................138
v& v& v&
Chapter 37. Gastroesophageal Reflux and Peptic Ulcer Disease ......................................................................146
v& v& v& v& xv v& v&
Chapter 38. Headaches .......................................................................................................................................149
v& v&
Chapter 39. Heart Failure...................................................................................................................................153
v& v& v&
Chapter 40. HIV Disease and Acquired Immunodeficiency Syndrome ............................................................158
v& v& v& v& xv v& v&
Chapter 41. Menopausal Hormone Therapy .....................................................................................................161
v& v& v& v&
,Chapter 42. Hyperlipidemia ...............................................................................................................................164
v& v&
Chapter 43. Hypertension...................................................................................................................................169
v& v&
Chapter 44. Hyperthyroidism and Hypothyroidism ..........................................................................................174
v& v& v& v&
Chapter 45. Obesity ...........................................................................................................................................177
v& v&
Chapter 46. Pain Management: Acute and Chronic Pain ..................................................................................181
v& v& v& v& v& v& v&
Chapter 47. Pneumonia ......................................................................................................................................185
v& v&
Chapter 48. Sexually Transmitted Diseases and Vaginitis ..................................................................................187
v& v& v& xv v& xv
Chapter 49. Substance Use Disorders ................................................................................................................190
v& v& v& v&
Chapter 50. Tuberculosis ...................................................................................................................................195
v& v&
Chapter51. UpperRespiratory Tract Infection, Pharyngitis, Sinusitis,Otitis Media, and Otitis Externa .............197
v& v& xv v& v& xv v& xv v&
Chapter 52. Urinary Tract Infections .................................................................................................................200
v& v& v& v&
Chapter 53. Women as Patients .........................................................................................................................203
v& v& v& v&
Chapter 54. Men as Patients ................................................................................................................................207
v& v& xv xv
Chapter 55. Pediatric Patients ............................................................................................................................209
v& v& v&
Chapter 57. Geriatric Patients ............................................................................................................................213
v& v& v&
, Woo 1
Pharmacotherapeutics for APN Prescribers, v& v& v& v& Ch01
6e
Chapter 1. The Role of the Advanced Practice Nurse as Prescriber
v& v& xv xv v& xv v& xv v& v&
MULTIPLE CHOICE v&
1. Nurse practitioner prescriptive authority is regulated by:
v& v& v& v& v& v&
A. The National Council of State Boards of Nursing
v& v& v& v& v& xv v&
B. The U.S. Drug Enforcement Administration
v& v& v& xv
C. The State Board of Nursing for each state
v& v& xv v& v& v& v&
D. The State Board of Pharmacy
v& v& v& v&
ANS: v & v & C PTS: 1
2. Thebenefits to the patient of having an advanced practice registered nurse (APRN) prescriber in
v& xv xv v& v& v& xv v& xv v& v&
cl ude:
v&
A. Nurses knowmoreabout pharmacology than other prescribers becausethey takeit b
v& xv v& v& v& v& v& v&
ot h in their basic nursing program and in their APRN program.
v& v& v& v& v& v& v& xv v& v& v&
B. Nurses care for thepatient from a holistic approach and includethepatient in de
xv v& v& xv v& xv v& v& xv xv v&
c ision-making regarding their care.
v& v& v& v&
C. APRNs are less likely to prescribe narcotics and other controlledsubstances.
v& v& v& v& v& v& v& v& v&
D. APRNs are abletoprescribe independentlyinallstates, whereas a physician’s as
v& xv v& v& xv v&
s istant needs to have a physician supervising their practice.
v& v& v& v& v& v& v& v& v&
ANS: v & v & B PTS: 1
3. Clinical judgment in prescribing includes:
v& v& v& v&
A. Factoring in the cost to the patient of the medication prescribed
v& v& v& v& v& v& xv v& v& v&
B. Always prescribing the newest medication available for the diseaseprocess
v& v& v& v& v& v& v& v&
C. Handing out drug samples to poor patients
v& v& v& v& xv v&
D. Prescribing all generic medications to cut costs v& v& v& v& v& xv
ANS: v & v & A PTS: 1
4. The process for choosing an effective drug for a disorder includes:
v& v& v& v& v& v& v& v& v& v&
A. Asking the patient what drug they think would work best for them
v& v& v& v& v& v& v& v& v& v& v&
B. Consulting nationally recognized guidelines for diseasemanagement
v& v& v& v& v&
C. Prescribing medications that are available as samples before writing a prescription
v& v& xv v& v& xv v& v& v& v&
D. Following U.S. Drug Enforcement Administration guidelines forprescribing
v& v& v& v& xv v&
ANS: v & v & B PTS: 1
5. Nonintentional nonadherence of drug therapy may occur due to:
v& v& v& v& v& v& v& v&
A. Belief that medication does not work
v& v& xv v& xv
B. Adverse drug reactions v& v&
C. Chronic conditions that require dailytherapy
v& v& v& v&
D. Forgetfulness ordistraction v&
ANS: v & v & D PTS: 1
